[go: up one dir, main page]

EP1991569A4 - BY ELECTROMAGNETICALLY STIMULATED, LIVING MAMMALIAN CELLS PRODUCED NATIVE GLYCOSYLATED BIOLOGICAL MOLECULAR MOLECULES - Google Patents

BY ELECTROMAGNETICALLY STIMULATED, LIVING MAMMALIAN CELLS PRODUCED NATIVE GLYCOSYLATED BIOLOGICAL MOLECULAR MOLECULES

Info

Publication number
EP1991569A4
EP1991569A4 EP06748309A EP06748309A EP1991569A4 EP 1991569 A4 EP1991569 A4 EP 1991569A4 EP 06748309 A EP06748309 A EP 06748309A EP 06748309 A EP06748309 A EP 06748309A EP 1991569 A4 EP1991569 A4 EP 1991569A4
Authority
EP
European Patent Office
Prior art keywords
mammalian cells
cells produced
living mammalian
biological molecular
molecular molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06748309A
Other languages
German (de)
French (fr)
Other versions
EP1991569A2 (en
Inventor
Thomas J Goodwin
Donnie Rudd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regenetech Inc
National Aeronautics and Space Administration NASA
Original Assignee
Regenetech Inc
National Aeronautics and Space Administration NASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenetech Inc, National Aeronautics and Space Administration NASA filed Critical Regenetech Inc
Publication of EP1991569A2 publication Critical patent/EP1991569A2/en
Publication of EP1991569A4 publication Critical patent/EP1991569A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2053—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP06748309A 2006-03-07 2006-03-07 BY ELECTROMAGNETICALLY STIMULATED, LIVING MAMMALIAN CELLS PRODUCED NATIVE GLYCOSYLATED BIOLOGICAL MOLECULAR MOLECULES Withdrawn EP1991569A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/008071 WO2007102812A2 (en) 2006-03-07 2006-03-07 Natively glycosylated mammalian biological molecules produced by eletromagnetically stimulating living mammalian cells

Publications (2)

Publication Number Publication Date
EP1991569A2 EP1991569A2 (en) 2008-11-19
EP1991569A4 true EP1991569A4 (en) 2009-12-23

Family

ID=38475285

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06748309A Withdrawn EP1991569A4 (en) 2006-03-07 2006-03-07 BY ELECTROMAGNETICALLY STIMULATED, LIVING MAMMALIAN CELLS PRODUCED NATIVE GLYCOSYLATED BIOLOGICAL MOLECULAR MOLECULES

Country Status (4)

Country Link
EP (1) EP1991569A4 (en)
CN (1) CN101213206A (en)
IL (1) IL188396A0 (en)
WO (1) WO2007102812A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2944019B1 (en) * 2009-04-03 2011-04-22 Biomerieux Sa METHOD FOR DETERMINING PRODEFENSIN-A6 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
WO2013148147A1 (en) 2012-03-26 2013-10-03 The U.S.A., As Represented By The Secretary Dept. Of Health And Human Services Dna methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
US11162073B2 (en) 2015-12-03 2021-11-02 The Brigham And Women's Hospital, Inc. Methods for generating functional hematopoietic stem cells
CN107541790B (en) * 2016-06-24 2021-07-06 上海交通大学 Human lectin/human-like lectin chip for glycosylation detection and preparation method
CN113252616B (en) * 2021-01-29 2022-05-03 厦门大学 Glycosylation research method of exosome
CN118147232B (en) * 2024-05-09 2024-07-19 中国人民解放军联勤保障部队第九二〇医院 Construction method and application of over-expressed TPS1 mesenchymal stem cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003520A1 (en) * 1984-12-04 1986-06-19 Genetics Institute, Inc. Method for the production of erythropoietin
GB2169312A (en) * 1985-01-02 1986-07-09 Beaconsfield Tina A method for producing proteins
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348191B1 (en) * 1986-07-08 2002-02-19 Genetics Institute, Inc. Production and use of IL-6
US20070048253A1 (en) * 2004-06-30 2007-03-01 Goodwin Thomas J Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986003520A1 (en) * 1984-12-04 1986-06-19 Genetics Institute, Inc. Method for the production of erythropoietin
GB2169312A (en) * 1985-01-02 1986-07-09 Beaconsfield Tina A method for producing proteins
US20050009161A1 (en) * 2002-11-01 2005-01-13 Jackson Streeter Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FISHER S J ET AL: "EFFECT OF A PULSED ELECTROMAGNETIC FIELD ON PLASMA MEMBRANE PROTEIN GLYCOSYLATION", JOURNAL OF BIOELECTRICITY, vol. 5, no. 2, 1986, pages 253 - 268, XP009125275, ISSN: 0730-823X *
HOGLUND M: "GLYCOSYLATED AND NON-GLYCOSYLATED RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) - WHAT IS THE DIFFERENCE?", MEDICAL ONCOLOGY, SCIENCE AND TECHNOLOGY LETTERS, NORTHWOOD, GB, vol. 15, no. 4, 1 December 1998 (1998-12-01), pages 229 - 233, XP009027777, ISSN: 1357-0560 *
KUBOTA N ET AL: "Structural characterization of natural and recombinant human granulocyte colony-stimulating factors.", JOURNAL OF BIOCHEMISTRY MAR 1990, vol. 107, no. 3, March 1990 (1990-03-01), pages 486 - 492, XP009125309, ISSN: 0021-924X *
LELKES P I ET AL: "GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells.", IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY. ANIMAL MAY 1997, vol. 33, no. 5, May 1997 (1997-05-01), pages 344 - 351, XP002553931, ISSN: 1071-2690 *

Also Published As

Publication number Publication date
WO2007102812A3 (en) 2007-12-21
WO2007102812A9 (en) 2008-02-21
CN101213206A (en) 2008-07-02
IL188396A0 (en) 2008-08-07
EP1991569A2 (en) 2008-11-19
WO2007102812A2 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
BRPI0716762A2 (en) cell culture improvements
DK2064334T3 (en) ALDEHYDAY, APPLICATIONS THEREOF IN SITE SPECIFIC PROTEIN MODIFICATION
PL2634242T3 (en) Improved cell culture
EP2260284B8 (en) Flow cells and manifolds having an electroosmotic pump
DK1828065T3 (en) PROCEDURE FOR INCREASED MANUFACTURING BIOGAS IN TERMOFILE, ANAEROBE FERMENTORS
ATE538138T1 (en) IMAGING-BASED QUANTIFICATION OF MOLECULAR TRANSLOCATION
EP2249895A4 (en) BLOOD PUMP ELEMENT IN PLATINUM-COBALT-BORE
EP2128242A4 (en) CELL CULTURE MODULE
EP2297182A4 (en) SUPER-LOADED PROTEINS FOR CELL PENETRATION
DE602006016389D1 (en) Partially passive fuel cell system
DK2522717T3 (en) Oligopeptide-free cell culture media
EP2258464A4 (en) HUMIDIFIER MEMBRANE MODULE
EP1938390A4 (en) SOLAN CELLS WITH NANOCRYSTALS PRODUCED FROM A SOLUTION
EP1882736A4 (en) RECIPIENT CELL CULTURE
EP1916731A4 (en) FUEL CELL SYSTEM
DE112006003337B8 (en) The fuel cell system
DE602007008627D1 (en) Cell culture medium
DE602006014676D1 (en) FESTPOLYMER ELECTROLYTE MEMBRANE, PRODUCTION METHOD AND FUEL CELL
DE602006012891D1 (en) fuel cell
IL188396A0 (en) Natively glycosylated mammalian biological molecules prouced by eletromagnetically stimulating living mammalian cells
EP1988804A4 (en) MICROFLUIDIC CELL CULTURE MEDIUM
FI20070976A0 (en) Fuel Pump
DK2070144T3 (en) FUEL CELL SYSTEM
DE602007007302D1 (en) FUEL CELL
WO2008096570A1 (en) Microchip and microchip inspection system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080124

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091120

17Q First examination report despatched

Effective date: 20100310

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100921